vs
CSW INDUSTRIALS, INC.（CSW）与GE医疗（DHC）财务数据对比。点击上方公司名可切换其他公司
GE医疗的季度营收约是CSW INDUSTRIALS, INC.的1.6倍（$379.6M vs $233.0M），CSW INDUSTRIALS, INC.净利率更高（4.4% vs -5.6%，领先10.0%），CSW INDUSTRIALS, INC.同比增速更快（20.3% vs -0.0%），CSW INDUSTRIALS, INC.自由现金流更多（$22.7M vs $-166.4M），过去两年CSW INDUSTRIALS, INC.的营收复合增速更高（5.1% vs 1.2%）
GE医疗是一家总部位于美国伊利诺伊州芝加哥市的医疗科技企业，业务涵盖四大板块：医疗影像设备，包括分子成像、CT、核磁共振、妇科健康筛查及X光系统；超声设备；患者护理解决方案，聚焦远程患者监测、麻醉呼吸护理、心脏诊断及婴幼儿护理；此外还涉及医药相关领域，是全球医疗行业的知名企业。
CSW vs DHC — 直观对比
营收规模更大
DHC
是对方的1.6倍
$233.0M
营收增速更快
CSW
高出20.3%
-0.0%
净利率更高
CSW
高出10.0%
-5.6%
自由现金流更多
CSW
多$189.2M
$-166.4M
两年增速更快
CSW
近两年复合增速
1.2%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $233.0M | $379.6M |
| 净利润 | $10.3M | $-21.2M |
| 毛利率 | 39.7% | — |
| 营业利润率 | 7.4% | -12.6% |
| 净利率 | 4.4% | -5.6% |
| 营收同比 | 20.3% | -0.0% |
| 净利润同比 | -61.9% | 75.7% |
| 每股收益（稀释后） | $0.62 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CSWDHC
| Q4 25 | $233.0M | $379.6M | ||
| Q3 25 | $277.0M | $388.7M | ||
| Q2 25 | $263.6M | $382.7M | ||
| Q1 25 | $230.5M | $386.9M | ||
| Q4 24 | $193.6M | $379.6M | ||
| Q3 24 | $227.9M | $373.6M | ||
| Q2 24 | $226.2M | $371.4M | ||
| Q1 24 | $210.9M | $370.8M |
净利润CSWDHC
| Q4 25 | $10.3M | $-21.2M | ||
| Q3 25 | $40.7M | $-164.0M | ||
| Q2 25 | $40.9M | $-91.6M | ||
| Q1 25 | $35.1M | $-9.0M | ||
| Q4 24 | $26.9M | $-87.4M | ||
| Q3 24 | $36.1M | $-98.7M | ||
| Q2 24 | $38.6M | $-97.9M | ||
| Q1 24 | $31.8M | $-86.3M |
毛利率CSWDHC
| Q4 25 | 39.7% | — | ||
| Q3 25 | 43.0% | — | ||
| Q2 25 | 43.8% | — | ||
| Q1 25 | 44.2% | — | ||
| Q4 24 | 41.4% | — | ||
| Q3 24 | 45.6% | — | ||
| Q2 24 | 47.5% | — | ||
| Q1 24 | 44.4% | — |
营业利润率CSWDHC
| Q4 25 | 7.4% | -12.6% | ||
| Q3 25 | 20.5% | -43.4% | ||
| Q2 25 | 20.8% | -24.5% | ||
| Q1 25 | 19.5% | -2.7% | ||
| Q4 24 | 15.3% | -26.1% | ||
| Q3 24 | 22.6% | -26.5% | ||
| Q2 24 | 24.3% | -23.0% | ||
| Q1 24 | 21.0% | -23.7% |
净利率CSWDHC
| Q4 25 | 4.4% | -5.6% | ||
| Q3 25 | 14.7% | -42.2% | ||
| Q2 25 | 15.5% | -23.9% | ||
| Q1 25 | 15.2% | -2.3% | ||
| Q4 24 | 13.9% | -23.0% | ||
| Q3 24 | 15.8% | -26.4% | ||
| Q2 24 | 17.1% | -26.3% | ||
| Q1 24 | 15.1% | -23.3% |
每股收益（稀释后）CSWDHC
| Q4 25 | $0.62 | $-0.09 | ||
| Q3 25 | $2.41 | $-0.68 | ||
| Q2 25 | $2.43 | $-0.38 | ||
| Q1 25 | $2.05 | $-0.04 | ||
| Q4 24 | $1.60 | $-0.37 | ||
| Q3 24 | $2.26 | $-0.41 | ||
| Q2 24 | $2.47 | $-0.41 | ||
| Q1 24 | $2.03 | $-0.36 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $40.2M | $105.4M |
| 总债务越低越好 | — | $2.4B |
| 股东权益账面价值 | $1.1B | $1.7B |
| 总资产 | $2.3B | $4.4B |
| 负债/权益比越低杠杆越低 | — | 1.47× |
8季度趋势，按日历期对齐
现金及短期投资CSWDHC
| Q4 25 | $40.2M | $105.4M | ||
| Q3 25 | $31.5M | $201.4M | ||
| Q2 25 | $38.0M | $141.8M | ||
| Q1 25 | $225.8M | $302.6M | ||
| Q4 24 | $213.8M | $144.6M | ||
| Q3 24 | $273.2M | $256.5M | ||
| Q2 24 | $18.9M | $265.6M | ||
| Q1 24 | $22.2M | $207.1M |
总债务CSWDHC
| Q4 25 | — | $2.4B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $800.1M | — | ||
| Q4 24 | — | $3.1B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $166.0M | — |
股东权益CSWDHC
| Q4 25 | $1.1B | $1.7B | ||
| Q3 25 | $1.1B | $1.7B | ||
| Q2 25 | $1.1B | $1.9B | ||
| Q1 25 | $1.1B | $1.9B | ||
| Q4 24 | $1.0B | $2.0B | ||
| Q3 24 | $1.0B | $2.0B | ||
| Q2 24 | $650.2M | $2.1B | ||
| Q1 24 | $615.7M | $2.2B |
总资产CSWDHC
| Q4 25 | $2.3B | $4.4B | ||
| Q3 25 | $1.5B | $4.7B | ||
| Q2 25 | $1.5B | $4.8B | ||
| Q1 25 | $1.4B | $5.0B | ||
| Q4 24 | $1.4B | $5.1B | ||
| Q3 24 | $1.4B | $5.3B | ||
| Q2 24 | $1.1B | $5.3B | ||
| Q1 24 | $1.0B | $5.3B |
负债/权益比CSWDHC
| Q4 25 | — | 1.47× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | — | 1.56× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.27× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $28.9M | $-19.6M |
| 自由现金流经营现金流 - 资本支出 | $22.7M | $-166.4M |
| 自由现金流率自由现金流/营收 | 9.8% | -43.8% |
| 资本支出强度资本支出/营收 | 2.6% | 38.7% |
| 现金转化率经营现金流/净利润 | 2.81× | — |
| 过去12个月自由现金流最近4个季度 | $162.0M | $-280.3M |
8季度趋势，按日历期对齐
经营现金流CSWDHC
| Q4 25 | $28.9M | $-19.6M | ||
| Q3 25 | $61.8M | $-49.3M | ||
| Q2 25 | $60.6M | $53.0M | ||
| Q1 25 | $27.3M | $-3.2M | ||
| Q4 24 | $11.6M | $112.2M | ||
| Q3 24 | $66.8M | $21.1M | ||
| Q2 24 | $62.7M | $44.3M | ||
| Q1 24 | $22.4M | $28.6M |
自由现金流CSWDHC
| Q4 25 | $22.7M | $-166.4M | ||
| Q3 25 | $58.7M | $-89.8M | ||
| Q2 25 | $57.7M | $18.8M | ||
| Q1 25 | $22.8M | $-42.9M | ||
| Q4 24 | $8.5M | $-89.5M | ||
| Q3 24 | $61.3M | $-26.1M | ||
| Q2 24 | $59.6M | $3.3M | ||
| Q1 24 | $17.5M | $-18.1M |
自由现金流率CSWDHC
| Q4 25 | 9.8% | -43.8% | ||
| Q3 25 | 21.2% | -23.1% | ||
| Q2 25 | 21.9% | 4.9% | ||
| Q1 25 | 9.9% | -11.1% | ||
| Q4 24 | 4.4% | -23.6% | ||
| Q3 24 | 26.9% | -7.0% | ||
| Q2 24 | 26.3% | 0.9% | ||
| Q1 24 | 8.3% | -4.9% |
资本支出强度CSWDHC
| Q4 25 | 2.6% | 38.7% | ||
| Q3 25 | 1.1% | 10.4% | ||
| Q2 25 | 1.1% | 8.9% | ||
| Q1 25 | 2.0% | 10.2% | ||
| Q4 24 | 1.6% | 53.1% | ||
| Q3 24 | 2.4% | 12.6% | ||
| Q2 24 | 1.4% | 11.0% | ||
| Q1 24 | 2.3% | 12.6% |
现金转化率CSWDHC
| Q4 25 | 2.81× | — | ||
| Q3 25 | 1.52× | — | ||
| Q2 25 | 1.48× | — | ||
| Q1 25 | 0.78× | — | ||
| Q4 24 | 0.43× | — | ||
| Q3 24 | 1.85× | — | ||
| Q2 24 | 1.62× | — | ||
| Q1 24 | 0.71× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CSW
| Contractor Solutions Segment | $166.3M | 71% |
| Specialized Reliability Solutions Segment | $38.2M | 16% |
| Engineered Building Solutions Segment | $28.5M | 12% |
DHC
| Senior Housing Operating Portfolio Segment | $323.4M | 85% |
| Rental Income | $56.2M | 15% |
